Behavioral Core B
Behavioral Core B
批准号:
10676992
负责人:
Rachel Elizabeth Miller
金额:
$15.92万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-14 至 2026-08-31
关键词:
AddressAnalgesicsAnimal ModelAnimalsAnxietyArthritisBehaviorBehavior assessmentBehavioralBehavioral AssayBiological AssayChicagoCollaborationsCommunitiesConsultationsDegenerative polyarthritisDevelopmentDiseaseDisease modelEducational ActivitiesEducational MaterialsEquipmentEvaluationExperimental ModelsFemaleFosteringGeographyGoalsInternationalLaboratoriesLeadershipModelingMusculoskeletalMusculoskeletal DiseasesMusculoskeletal PainNeeds AssessmentNeurobiologyOutcomePainPathway interactionsPatientsPersonsPhenotypePre-Clinical ModelProprioceptionProtocols documentationQualifyingResearchResearch PersonnelResearch SupportResearch TrainingResourcesRheumatismRheumatoid ArthritisRodentRodent ModelServicesSocial BehaviorSurveysTechnical ExpertiseTestingTimeTrainingTraining Activitybehavior measurementbehavior testdesignexperienceinnovationmalenew technologynovelnovel therapeuticspain behaviorpre-clinicalpreclinical studypreventsomatosensoryspontaneous painsynergismtesting servicestoolvirtualweb portal
中文摘要
项目总结
英文摘要
Project summary
The overarching goal of the Chicago Center on Musculoskeletal Pain (C-COMP) is to foster and support
research and training aimed at understanding the mechanisms underlying pain in musculoskeletal (MSK)
disease, with the ultimate goal of better managing and preventing it. Assessment of disease-specific pain-
related behaviors and other somatosensory changes in appropriate preclinical models of rheumatic and MSK
diseases is one of the cornerstones for the study of mechanisms underlying pain associated with these
diseases, necessary for the development of new therapeutics for MSK pain. The Behavioral Core B will
support this goal by providing unique resources, world class expertise, and effective training to assess
behavioral changes in animal models of MSK and rheumatic diseases. We will capitalize on our combined
expertise in models of osteoarthritis and other MSK diseases, and we will engage world class experts in rodent
pain behaviors to provide continued guidance. This approach will support much needed high-quality research
and training in this field and will facilitate a more wide-spread use of appropriate behavioral measures as
outcomes in preclinical studies of MSK disease. Such a service is a prerequisite for exploring mechanisms
underlying pain associated with MSK diseases, and for increasing the translational utility of animal models.
Ultimately, we expect that choosing the right behaviors in the right models will aid the development of novel,
safe, and efficacious analgesics. The behavioral assays offered in Core B have been chosen to synergize with
Neurobiology Core C, which will further enable mechanistic evaluation of pain pathways. Our own combined
cumulative experience and established innovation and international leadership in the behavioral
characterization of rodent models of MSK diseases provides us with unique qualifications to advise and
support researchers about the most efficient strategies to evaluate behavioral changes in MSK models. The
Core will achieve its objectives through the following aims: Aim 1. Establish a centralized resource to
facilitate behavioral assays in MSK disease models. We will provide a full panel of behavioral assays that
cover all types of somatosensory changes. The Core will provide hands-on training in animal behavioral
testing, customized protocols, equipment, and testing space. Aim 2. Provide a consultation service, and a
customized, full-service option for applying behavioral testing to preclinical models of arthritis and MSK
disease. The Core will provide scientific guidance for the design of studies and consulting services on how to
apply behavioral testing to MSK models. The Core will provide technical expertise to make customized, full-
service behavioral testing options available to laboratories, including labs outside of Chicago. Aim 3. Train the
research community in evaluating behavioral changes in models of arthritis and other MSK diseases.
We will provide both in person and virtual training, present seminars and develop educational material to
enhance Center investigators’ understanding of how to integrate behavioral testing into their laboratories.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of Mechanosensation Pathways in Osteoarthritis Joint Damage and Pain
-
批准号:10584598
-
项目类别:
-
资助金额:$34.56万
-
财政年份:2021
-
负责人:Rachel Elizabeth Miller
-
依托单位:
Behavioral Core B
-
批准号:10488599
-
项目类别:
-
资助金额:$16.05万
-
财政年份:2021
-
负责人:Rachel Elizabeth Miller
-
依托单位:
The Role of Mechanosensation Pathways in Osteoarthritis Joint Damage and Pain
-
批准号:10861577
-
项目类别:
-
资助金额:$27.43万
-
财政年份:2021
-
负责人:Rachel Elizabeth Miller
-
依托单位:
The Role of Mechanosensation Pathways in Osteoarthritis Joint Damage and Pain
-
批准号:10382232
-
项目类别:
-
资助金额:$34.82万
-
财政年份:2021
-
负责人:Rachel Elizabeth Miller
-
依托单位:
Biomechanical Pathways Associated with Osteoarthritis Pain
-
批准号:9307698
-
项目类别:
-
资助金额:$11.52万
-
财政年份:2016
-
负责人:Rachel Elizabeth Miller
-
依托单位:
MCP-1/CCR2 Signaling in the Maintenance of OA Pathology and Associated Pain
-
批准号:8455056
-
项目类别:
-
资助金额:$5.67万
-
财政年份:2013
-
负责人:Rachel Elizabeth Miller
-
依托单位:
MCP-1/CCR2 Signaling in the Maintenance of OA Pathology and Associated Pain
-
批准号:8701869
-
项目类别:
-
资助金额:$5.96万
-
财政年份:2013
-
负责人:Rachel Elizabeth Miller
-
依托单位:
海外基金